Results 101 to 110 of about 1,440 (183)

Challenges and practical considerations in the management of blastic plasmacytoid dendritic cell neoplasm: A single-center experience

Leukemia Research Reports
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a rare and often life-threatening complex hematologic malignancy that can commonly infiltrate the skin, lymph nodes, central nervous system, and bone marrow.
Haripriya Andanamala, Naveen Pemmaraju, Taha Al-Juhaishi   +2 more
doaj   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights from Countries of the Gulf Cooperation Council

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive orphan hematopoietic malignancy characterized by cutaneous and systemic hematologic involvement.
Ayman Al Hejazi, Phyu P. Aung, Nasir Bakshi, Robert S. Ohgami, Haitham Khogeer, Hatim Al-Maghraby, Ahmad S. Alotaibi, Rania Medhat Seliem, Heba Raslan, Areej Al Mugairi, Ramesh Pandita   +10 more
core   +1 more source

A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm

, 2016
International audienceBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and largely incurable hematologic malignancy originating from plasmacytoid dendritic cells (pDCs).
Wright, George, Shaffer, Arthur L, Chaperot, Laurence, Kelly, Priscilla N, Hou, Zhiying Esther, Pittaluga, Stefania, Marcucci, Guido, Evbuomwan, Moses O, Forman, Stephen J, Xiao, Wenming, Plumas, Joel, Thomas, Craig J, Ferrer, Marc, Ganapathi, Karthik, Guha, Rajarshi, Staudt, Louis M, Huang, da Wei, Jaffe, Elaine S, Ceribelli, Michele, Zhang, Xiaohu, Reizis, Boris   +20 more
core   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights

, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare clonal hematologic malignancy of plasmacytoid dendritic cell precursors. The presentation and clinical course of BPDCN is widely heterogeneous and was most recently categorized as a distinct ...
Venugopal, Sangeetha, Lane, Andrew A., Mascarenhas, John, Zhou, Selena, El Jamal, Siraj M.   +4 more
core   +1 more source

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) international registry: Assessment of the allo-HCT outcomes

Background: Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an underdiagnosed rare disease with poor outcomes and limited treatment options.
Attardi, Enrico, Voskanyan, Astghik, Peng, Ching-Tien, Ohannessian, Robin, Konopleva, Marina, Tamamyan, Gevorg, Michael, Michalis, Martelli, Maria Paola, Mehra, Shefali, Bedirian, Karen, Martirosyan, Nare, Komrokji, Rami, Abramashvili, Mariam, Ivanyan, Arusyak, Kutluk, Tezer, Tuğcu, Deniz, Papyan, Ruzanna, Alhuraiji, Ahmad, Tekkesin, Funda, Taylor, Justin, Al-Jadiry, Mazin Faisal, Ghali, Hasanein, Voso, Maria Teresa, Su, Min-Yu, Badikyan, Maria, Stancioaica, Maria Camelia, Grigoryan, Hayk, Hovsepyan, Shushan, El-Ashwah, Shaimaa, Harutyunyan, Lusine, Owen, Carolyn, Ghahramanyan, Nerses, Bakhshi, Sameer, Maghaqyan, Hasmik, Kebudi, Rejin, Pemmaraju, Naveen, Kotoucek, Pavel, Bardakhchyan, Samvel, Elashwah, Salma, Kazandjian, Dickran, Coriu, Daniel, Alencar, Alvaro, Totogashvili, Nino   +42 more
core   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry: Tagraxofusp Cohort Treatment Results

Background: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an orphan malignancy defined by the WHO as affection fewer than 65 per 100,000 people and by the U.S. FDA as affecting less than 200,000 people in the U.S..
Attardi, Enrico, Voskanyan, Astghik, Alencar, Alvaro J, Peng, Ching-Tien, Ohannessian, Robin, Konopleva, Marina, Tamamyan, Gevorg, Martelli, Maria Paola, Mehra, Shefali, Bedirian, Karen, Martirosyan, Nare, Komrokji, Rami S., Abramashvili, Mariam, Kotoucek, Pavel P, Ivanyan, Arusyak, Kutluk, Tezer, Tuğcu, Deniz, Papyan, Ruzanna, Alhuraiji, Ahmad, Tekkesin, Funda, Taylor, Justin, Al-Jadiry, Mazin Faisal, Ghali, Hasanein, Voso, Maria Teresa, Su, Min-Yu, Al Ali, Najla H., Badikyan, Maria, Stancioaica, Maria Camelia, Hovsepyan, Shushan, El-Ashwah, Shaimaa, Danelyan, Samvel, Owen, Carolyn, Ghahramanyan, Nerses, Bakhshi, Sameer, Maghaqyan, Hasmik, Kebudi, Rejin, Pemmaraju, Naveen, Bardakhchyan, Samvel, Sergi, Consolato M, Elashwah, Salma, Kazandjian, Dickran, Coriu, Daniel, Totogashvili, Nino   +42 more
core   +1 more source

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo

, 2012
AIM: Blastic plasmacytoid dendritic cell neoplasm (BPDNC) is a rare tumour, which stems from plasmacytoid dendritic cells. Although the aetiology is still unclear, in the last few years various reports suggested a potential role of chromosomal ...
PILERI, ALESSANDRO, Delfino C., PILERI, STEFANO, Grandi V., AGOSTINELLI, CLAUDIO, Pimpinelli N.   +5 more
core   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) [PDF]

Egyptian Journal of Hematology and Bone Marrow Transplantation, 2017
openaire   +1 more source

Case Report: Blastic plasmacytoid dendritic cell neoplasm mimicking systemic lymphoma: a multidisciplinary diagnostic challenge. [PDF]

Front Med (Lausanne)
Lv B, Rong Q, Li Y, Zhang D.
europepmc   +1 more source